Project profile — Joint UN Programme on HIV/AIDS (UNAIDS) - Institutional Support 2014

• Africa, regional (50.00%)
• America, regional (25.00%)
• Asia, regional (25.00%)

• Population Policies/Programmes And Reproductive Health: STD control including HIV/AIDS (13040) (100.00%)

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (significant objective)
• Youth Issues (significant objective)
• Indigenous Issues (not targeted)
• Disability (significant objective)
• ICT as a tool for development (not targeted)

This grant represents Canada’s institutional support to the Joint UN Programme on HIV/AIDS (UNAIDS). UNAIDS uses these funds, along with other donors funding, to achieve its mandate. As the United Nation’s (UN) principal advocate for global action on HIV/AIDS, UNAIDS leads, strengthens and supports an expanded response aimed at preventing the transmission of HIV, providing treatment and care for people living with the disease, reducing the vulnerability of individuals and communities to HIV, and alleviating the epidemic’s impact worldwide. Canada’s support to UNAIDS helps to maximize the reach of CIDA’s investments, and enables CIDA to influence the development and implementation of global HIV-related policies and practices.

Expected results for this funding include; Sexual transmission of HIV reduced by half, Vertical transmission of HIV eliminated and AIDS-related maternal mortality reduced by half, Universal access to antiretroviral therapy for people living with HIV who are eligible for treatment, HIV-specific needs of women and girls are addressed in at least half of all national HIV responses; and, zero tolerance for gender-based violence is achieved.

From 2003 to 2013, the number of new HIV infections among children declined by 57%. Marked gains have been made in bringing HIV treatment to scale; 26 countries in Latin America and the Caribbean have adopted ambitious regional post-2015 treatment targets, all countries in Eastern and Southern Africa are taking steps to implement the 2013 WHO consolidated antiretroviral treatment guidelines, and several countries in West and Central Africa are moving towards initiation of HIV treatment for all people living with HIV, regardless of CD4 cell count. The HIV prevention revolution is also advancing, with important leadership on prevention issues apparent in diverse countries.

• Proactive disclosure